The RayPlex Atezolizumab (Tecentriq®) ADA kit is a cytometric bead assay to quantitatively measure Atezolizumab (Tecentriq®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Rituximab ADA kit is a cytometric bead assay that quantitatively detects anti-drug antibodies by flow cytometry. Suitable for serum and plasma.
The RayPlex Daratumumab (Darzalex®) DA kit is a cytometric bead assay to quantitatively measure Daratumumab (Darzalex®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Infliximab (Remicade®) DA kit is a cytometric bead assay to quantitatively measure Infliximab (Remicade®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Sarilumab (Kevzara®) DA kit is a cytometric bead assay to quantitatively measure Sarilumab (Kevzara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Ustekinumab (Stelara®) DA kit is a cytometric bead assay to quantitatively measure Ustekinumab (Stelara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Ustekinumab (Stelara®) DA kit is a cytometric bead assay to quantitatively measure Ustekinumab (Stelara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.